Farmington, Connecticut 06030

  • Craniometaphyseal Dysplasia


CMD can be inherited in an autosomal dominant or recessive trait. CMD may also be caused by de novo mutations. The goal of this study is to identify genes and regulatory elements on chromosomes that are the cause for CMD. The investigators also study blood samples and tissue samples from patients to learn about the processes that lead to this disorder. The investigators long-term goal is to find mechanisms to slow down bone deposition in CMD patients.

Study summary:

CMD is a very rare bone disorder that affects mostly bones of the head (=cranial bones) but also long (=tubular) bones. Therefore, CMD has been added to the class of craniotubular bone disorders. There are a number of disorders in this group and sometimes they are difficult to distinguish. Typical signs for CMD are the lifelong bone deposition in bones of the face and head (=progressive craniofacial hyperostosis) and the widening of the ends of long bones (=metaphyseal flaring). Typical facial characteristics are wide-set eyes and a prominent jaw (=mandible). CMD is sometimes diagnosed in infants. The best way to confirm diagnosis is by molecular genetics.


Inclusion Criteria: - CMD; unaffected individuals only if part of a participating CMD family Exclusion Criteria: - No CMD; unaffected individuals only as part of a participating CMD family



Primary Contact:

Principal Investigator
Ernst J Reichenberger, PhD
UConn Health

Ernst J Reichenberger, PhD
Phone: 860-679-2062

Backup Contact:


Location Contact:

Farmington, Connecticut 06030
United States

Ernst J Reichenberger, PhD
Phone: 860-679-2062

Site Status: Recruiting

Data Source:

Date Processed: September 16, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.